Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure

被引:21
作者
Dawes, Martin G.
Coats, Andrew J.
Juszczak, Edmund
机构
[1] McGill Univ, Dept Family Med, Montreal, PQ H2W 1S4, Canada
[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[3] Univ Oxford, Ctr Stat Med, Oxford, England
关键词
ambulatory blood pressure monitoring; cohort; primary care; prognostic indicator; pulse pressure;
D O I
10.1097/01.mbp.0000209086.32493.bd
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives: To assess the prognostic value of daytime ambulatory blood pressure compared with routine clinic blood pressure in determining mortality. Methods: Prospective multicentre study in 48 general practices in Oxfordshire, a hypertension clinic in Oxford and a hypertension clinic in London. Results: A cohort of 10 129 patients from Oxford and London was followed up for a median of 8.2 years. Nine hundred and one deaths were recorded (8.9%) corresponding to a mortality rate per 1000 years of follow-up of 10.8 (99% confidence interval 9.9-11.8). Comparing the highest quartile for systolic ambulatory blood pressure with the lowest (>= 160 vs. < 135 mmHg) gives an estimated age sex-adjusted hazard ratio for mortality of 1.51 (95% confidence interval 1.25-1.83, P < 0.001). The corresponding comparison for clinic systolic blood pressure (>= 174 vs. < 148 mmHg) results in a hazard ratio of 1.02 (95% confidence interval 0.84-1.24, P = 0.9). Comparing ambulatory versus clinic systolic blood pressure (10 mmHg groupings) using nested statistical modelling, removal of the ambulatory blood pressure term from the baseline Cox model (nine 10 mmHg categories) resulted in a highly significant likelihood ratio test statistic of 52.5 (df = 8, P < 0.0001). The corresponding result for removal of the clinic blood pressure term was 18.1 (df = 8, P = 0.02), thus reinforcing the finding that ambulatory blood pressure monitoring has greater prognostic significance. Ambulatory blood pressure was also a better predictor of all-cause mortality both in patients taking medication and those not taking medication at the time of monitoring. Conclusion: Daytime ambulatory blood pressure monitoring is a much better prognostic indicator of all-cause mortality than clinic blood pressure.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 41 条
  • [1] Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population
    Antikainen, R
    Jousilahti, P
    Tuomilehto, J
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (05) : 577 - 583
  • [2] A REVIEW OF COMMON ERRORS IN THE INDIRECT MEASUREMENT OF BLOOD-PRESSURE - SPHYGMOMANOMETRY
    BAILEY, RH
    BAUER, JH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (24) : 2741 - 2748
  • [3] J-shaped relationship between blood pressure and mortality in hypertensive patients: New insights from a meta-analysis of individual-patient data
    Boutitie, F
    Gueyffier, F
    Pocock, S
    Fagard, R
    Boissel, JP
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (06) : 438 - 448
  • [4] Chalmers J, 1999, J HYPERTENS, V17, P151
  • [5] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [6] CLARK S, 1991, J HUM HYPERTENS, V5, P77
  • [7] Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension
    Clement, DL
    De Buyzere, ML
    De Bacquer, DA
    de Leeuw, PW
    Duprez, DA
    Fagard, RH
    Gheeraert, PJ
    Missault, LH
    Braun, JJ
    Six, RO
    Van Der Niepen, P
    O'Brien, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) : 2407 - 2415
  • [8] AMBULATORY PRESSURE MONITORING IN THE ASSESSMENT OF ANTIHYPERTENSIVE THERAPY
    COATS, AJS
    CONWAY, J
    SOMERS, VK
    ISEA, JE
    SLEIGHT, P
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 : 303 - 311
  • [9] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
    COLLINS, R
    PETO, R
    MACMAHON, S
    HEBERT, P
    FIEBACH, NH
    EBERLEIN, KA
    GODWIN, J
    QIZILBASH, N
    TAYLOR, JO
    HENNEKENS, CH
    [J]. LANCET, 1990, 335 (8693) : 827 - 838
  • [10] *COMM ANBPSM, 1980, LANCET, V1, P1261